ImageCyte Technologies
PrivateLast Round
Grant
Oct 1, 2025
Total Funding Raised
$10,000
Company Overview
ImageCyte Technologies operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Grant round in October 2025.
ImageCyte Technologies is a life science company that develops and manufactures high-density nanowell imaging plates to enhance single-cell imaging and biological research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImageCyte Technologies Comparables
Compare ImageCyte Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ibidi GmbH | 77% | |
| Cellvis | 76% | |
| Revvity, Inc. | 75% |
For institutional investors. Book with your work email.
ImageCyte Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2025 | ||||
| Early Funding | Aug 27, 2025 | ||||
| Accelerator | Jan 24, 2025 | ||||
| Accelerator | Oct 8, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ImageCyte Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Life Sciences BC | Accelerator |
| Innovate BC | Grant |
| HATCH Venture Builder | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Grew 300% QoQ from 1 to 4 employees.
- Oct 1, 2025
$10K grant received from Innovate BC.
For institutional investors. Book with your work email.
ImageCyte Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImageCyte Technologies's valuation, stock price, and market status.
Is ImageCyte Technologies a public or private company?
ImageCyte Technologies is a private company.
What is the current stock price of ImageCyte Technologies?
ImageCyte Technologies is a private company, so its shares have no public market price. Caplight tracks ImageCyte Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImageCyte Technologies worth (valuation)?
Valuation information for ImageCyte Technologies is not publicly available.
Can I buy ImageCyte Technologies stock?
ImageCyte Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImageCyte Technologies's last funding round?
ImageCyte Technologies's most recent funding round was Grant on October 1, 2025.
Who are the main investors in ImageCyte Technologies?
Key investors in ImageCyte Technologies include Life Sciences BC, Innovate BC, HATCH Venture Builder.
Will ImageCyte Technologies IPO soon?
No public IPO plans have been announced for ImageCyte Technologies.
How can I track ImageCyte Technologies secondary market activity?
Caplight tracks bids, offers, and trades in ImageCyte Technologies's shares on secondary markets.